Amjevita (adalimumab-atto) is a biosimilar for the biologic medication Humira (adalimumab). A biosimilar is a U.S. Food and Drug Administration (FDA) approved biologic product that is very similar to an already FDA-approved biologic.
Get your free resource and learn more about:
- How Amjevita works
- People who can take Amjevita
- Common side effects and possible risks
Resource last updated: January 2025